Search
Diethyltryptamine
go.drugbank.com/drugs/DB01460ExperimentalIllicitDiethyltryptamine (DET) is an orally active hallucinogenic agent and a substituted form of tryptamine.
Categories: Compounds used in a research, industrial, or household setting4-dimethylaminophenol
go.drugbank.com/drugs/DB13549ExperimentalCategories: Compounds used in a research, industrial, or household settingChlorophyll A
go.drugbank.com/drugs/DB02133ExperimentalCategories: Heterocyclic Compounds with 4 or More RingsIndole-3-carbinol
go.drugbank.com/drugs/DB12881InvestigationalIndole 3 Carbinol is under investigation in clinical trial NCT00033345 (Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer).
Categories: Compounds used in a research, industrial, or household settingCoptisine
go.drugbank.com/drugs/DB19308ExperimentalSynonyms: 6,7-dihydrobis(1,3)benzodioxolo(5,6-a:4',5'-g)quinolizinium, Bis(1,3)benzodioxolo(5,6-a:4',5'-g)quinolizinium, 6,7-dihydro-Categories: Heterocyclic Compounds with 4 or More RingsIsoluminol
go.drugbank.com/drugs/DB02041ExperimentalCategories: Compounds used in a research, industrial, or household settingAcrylic Acid
go.drugbank.com/drugs/DB02579InvestigationalA α,β-unsaturated monocarboxylic acid that is ethene substituted by a carboxy group.
Categories: Compounds used in a research, industrial, or household settingLomitapide
go.drugbank.com/drugs/DB08827ApprovedUnlike traditional statin therapy, which relies on the upregulation of LDL receptors to clear cholesterol, Lomitapide acts independently of the LDL receptor by preventing the assembly and secretion of … Lomitapide, marketed under the brand names Juxtapid (USA) and Lojuxta (EU), is a first-in-class, small-molecule inhibitor of microsomal triglyceride transfer protein (MTP).
Products: JUXTAPID® CÁPSULAS POR 20 MG, JUXTAPID® CÁPSULAS POR 5 MGVabicaserin
go.drugbank.com/drugs/DB12071InvestigationalVabicaserin has been used in trials studying the health services research and treatment of Schizophrenia.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome